India has set out norms for the public procurement of medicines, providing preference to domestic manufacturers that use significant local content. Localization requirements move progressively upwards under the new requirements, including for drugs not made in India.
The new norms, notified earlier this month, specify that formulations made in India will need to ensure a minimum of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?